Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

Lung cancer has recently been discovered to be an immunological targetable disease, on the basis of the exciting results of the randomized trials with immune checkpoint inhibitors. Nevertheless, the survival benefit appears to not be entirely captured by the usual outcome measures, thus requiring a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Lung Cancer Res
Main Authors: Pilotto, Sara, Carbognin, Luisa, Karachaliou, Niki, Garassino, Marina, Cuppone, Federica, Petraglia, Sandra, Rosell, Rafael, Tortora, Giampaolo, Bria, Emilio
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2015
Fag:
Review Article on Lung Cancer Immunotherapy
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700216/
https://ncbi.nlm.nih.gov/pubmed/26798579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2015.10.08
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker